Desloratadine

Description

Empowering Wellness with PharmAlliance International Labs’ Desloratadine Tablets

Welcome to PharmAlliance International Labs Private Limited, your partner in delivering excellence in pharmaceuticals. Introducing our Desloratadine Tablets, meticulously crafted to provide effective relief for patients battling allergic conditions, offering them respite from discomfort and a pathway to improved quality of life.

Understanding the Drug Class:

Desloratadine belongs to the esteemed class of second-generation antihistamines, renowned for their targeted approach to allergy relief. By selectively antagonizing the histamine H1 receptor, Desloratadine effectively blocks the action of histamine, thereby alleviating symptoms associated with allergic reactions. This mechanism of action makes it a cornerstone in the management of allergic rhinitis and chronic idiopathic urticaria, offering patients a route to respiratory and dermatological comfort.

Tailored Formulations for Optimal Convenience:

Our Desloratadine Tablets contain 5 mg of Desloratadine each, providing precision and potency in every dose. Packaged in blister packs containing 10 tablets each, our oral tablets are designed for convenient administration, ensuring ease of use and storage. Whether prescribed for seasonal allergies or chronic hives, PharmAlliance’s Desloratadine Tablets offer patients a reliable solution for allergic symptom management.

Comprehensive Indications and Usage Guidelines:

PharmAlliance’s Desloratadine Tablets are indicated for the relief of symptoms associated with allergic rhinitis (hay fever) and for the treatment of chronic idiopathic urticaria (hives) in adults and pediatric patients aged 6 months and older. With clear dosage instructions and flexible administration options, our Desloratadine Tablets empower patients to take control of their respiratory and dermatological health, enabling them to lead lives free from the constraints of allergic discomfort.

Pharmacokinetics and Pharmacodynamics:

Desloratadine is rapidly absorbed from the gastrointestinal tract after oral administration, with peak plasma concentrations achieved within 3 hours. The drug undergoes extensive hepatic metabolism to form its active metabolite, 3-hydroxy desloratadine. Desloratadine and its metabolite are primarily eliminated via renal excretion, with elimination half-lives ranging from 27 to 36 hours. Pharmacologically, Desloratadine exerts its effects by selectively blocking the histamine H1 receptor, thereby reducing the symptoms of allergic rhinitis and chronic idiopathic urticaria.

Safety and Side Effects Monitoring:

While generally well-tolerated, Desloratadine Tablets may cause some common side effects such as headache, fatigue, dry mouth, and gastrointestinal disturbances. Rare but serious side effects, including allergic reactions and palpitations, should be monitored closely, and healthcare providers should be informed of any concerning symptoms. At PharmAlliance, patient safety is paramount, and we remain committed to providing healthcare professionals with the necessary resources to ensure optimal patient care and safety.

Experience Relief with PharmAlliance International Labs:

Trust PharmAlliance International Labs Private Limited as your partner in respiratory and dermatological wellness. With our Desloratadine Tablets, patients can experience effective relief from allergic rhinitis and chronic idiopathic urticaria, enabling them to lead healthier, more fulfilling lives. For more information about our innovative pharmaceutical solutions, please contact us. Together, let’s embark on a journey towards respiratory and dermatological wellness and empower patients to embrace a life of comfort and vitality.